Your browser is no longer supported. Please, upgrade your browser.
INSY INSYS Therapeutics, Inc. daily Stock Chart
INSYS Therapeutics, Inc.
Index- P/E37.95 EPS (ttm)0.32 Insider Own0.10% Shs Outstand76.37M Perf Week12.01%
Market Cap918.73M Forward P/E38.07 EPS next Y0.32 Insider Trans16.82% Shs Float22.99M Perf Month22.13%
Income24.00M PEG0.58 EPS next Q0.00 Inst Own43.40% Short Float66.71% Perf Quarter-1.96%
Sales275.40M P/S3.34 EPS this Y49.20% Inst Trans-7.99% Short Ratio14.11 Perf Half Y-23.38%
Book/sh3.75 P/B3.21 EPS next Y2.60% ROA7.00% Target Price18.20 Perf Year-28.31%
Cash/sh2.22 P/C5.42 EPS next 5Y65.00% ROE9.30% 52W Range8.70 - 21.22 Perf YTD30.76%
Dividend- P/FCF18.27 EPS past 5Y28.50% ROI22.80% 52W High-43.31% Beta0.60
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin92.00% 52W Low38.28% ATR0.72
Employees510 Current Ratio3.10 Sales Q/Q-39.50% Oper. Margin13.10% RSI (14)62.12 Volatility9.75% 5.81%
OptionableYes Debt/Eq0.00 EPS Q/Q-99.30% Profit Margin8.70% Rel Volume1.54 Prev Close12.80
ShortableYes LT Debt/Eq0.00 EarningsMar 07 BMO Payout0.00% Avg Volume1.09M Price12.03
Recom1.80 SMA2014.55% SMA5019.77% SMA200-6.76% Volume1,672,195 Change-6.02%
Dec-21-16Reiterated RBC Capital Mkts Outperform $23 → $16
Sep-22-16Reiterated RBC Capital Mkts Outperform $32 → $26
Apr-12-16Reiterated Jefferies Buy $23 → $17
Apr-11-16Reiterated Piper Jaffray Overweight $46 → $28
Feb-24-16Reiterated Jefferies Buy $36 → $23
Feb-01-16Reiterated RBC Capital Mkts Outperform $49 → $44
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Feb-24-17 02:56PM  2 doctors face up to 20 years in prison for running a $40 million opioid 'pill mill' -6.02%
10:22AM  [$$] Alabama Doctors Convicted in Health-Care Fraud Case at The Wall Street Journal
07:49AM  INSYS Therapeutics (INSY) is in Overbought Territory: What's Next?
Feb-23-17 09:39AM  [2/23] This Weeks Earnings Revisions Movers -5.04%
Feb-22-17 03:52PM  Drug Addiction Treatment Stocks to Watch +6.56%
08:43AM  Are Options Traders Betting on a Big Move in Insys Therapeutics (INSY) Stock?
Feb-19-17 09:18AM  Marijuana Stocks: Plenty of Business Diversity, Yet One Common Theme at Motley Fool
Feb-17-17 05:40PM  Here's Why This Marijuana Stock Jumped 15% This Week at Motley Fool
Feb-16-17 04:51PM  INSYS Therapeutics, Inc.: Sudden move in price, will it continue?
09:30AM  Biotech Industry Shaping up to Have a Breakout Year in 2017: Today's Reports on Insys Therapeutics and Zosano Pharma Accesswire
Feb-15-17 09:41AM  Gurus' Worst Recent Investments +12.24%
07:00AM  Insys Therapeutics Announces Use of Cannabidiol Oral Solution for Compassionate Use Studies in Patients Completing Long-Term Safety Study GlobeNewswire
Feb-14-17 04:30PM  Insys Therapeutics, Inc. to Present at 2017 RBC Capital Markets Global Healthcare Conference GlobeNewswire
Feb-08-17 02:19PM  INSYS Therapeutics, Inc. Value Analysis (NASDAQ:INSY) : February 8, 2017
Feb-07-17 10:11AM  Innovative Marijuana-Based Medicines In the Making at Investopedia
07:20AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : February 7, 2017
Feb-06-17 08:15AM  Blog Coverage Auris Medical Expands Clinical Development Pipeline for Treatment of Meniere's Disease and Vestibular Vertigo Accesswire
Feb-04-17 02:02PM  Better Marijuana Stock to Buy: GW Pharmaceuticals or Insys Therapeutics? at Motley Fool
Feb-03-17 11:37PM  Trial Reveals Deep Ties Between Pair of Doctors and Fentanyl Maker at The Wall Street Journal
Feb-02-17 04:41PM  Why This Marijuana Stock Surged 11.3% Higher in January at Motley Fool
Feb-01-17 07:06AM  Trial Focuses on Ties Between Pain Doctors and Fentanyl Maker at The Wall Street Journal
Jan-31-17 06:16PM  Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing
Jan-30-17 02:13PM  3 Marijuana Stocks Ready to Soar in 2017 at Motley Fool
Jan-26-17 04:59PM  Marijuana Stocks: What to Watch in 2017 at Motley Fool
07:10AM  Research Reports Coverage on Biotech Stocks -- OncoGenex Pharma, INSYS Therapeutics, Threshold Pharma, and AmpliPhi Biosciences PR Newswire
Jan-25-17 02:09PM  Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs
Jan-24-17 02:29PM  6 Hot Stocks Among Shorts: Weight Watchers Moves Ahead Of The Pack
Jan-22-17 03:02PM  How Big Could the Opportunity Be for Marijuana Stocks in California? at Motley Fool
Jan-19-17 03:58PM  GW Pharmaceuticals' Biggest Win in 2016 at Motley Fool -6.00%
11:20AM  DoJ Takes Action On Insys For 'Unfair, Deceptive Marketing Practices' Of Fentanyl Drug
Jan-18-17 11:42AM  Lifshitz & Miller Law Firm Announces Investigation of Abeona Therapeutics Inc., Agile Therapeutics, Inc., Alere Inc., Floteck Industries, Inc., Insys Therapeutics Inc., MTS Systems Corporation, Ophthotech Corporation and Teekay Corporation PR Newswire +5.15%
11:29AM  Top 4 Medicinal Marijuana Stocks for 2017 at Investopedia
Jan-15-17 03:44PM  Donald Trump On Weed Legalization: Whats In Store For Marijuana Stocks? at Insider Monkey
Jan-14-17 03:21PM  Here's How Big the Opportunity Could Be for Marijuana Stocks at Motley Fool
Jan-12-17 04:52PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
02:09PM  ETFs with exposure to INSYS Therapeutics, Inc. : January 12, 2017
11:29AM  Insys Could Be The Next Major Short Squeeze Play
09:37AM  12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies at Insider Monkey
Jan-09-17 01:24PM  Here's Why Insys Therapeutics Plummeted 67.2% in 2016 at Motley Fool
06:50AM  Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board GlobeNewswire
Jan-04-17 04:30PM  Insys Therapeutics, Inc. to Present at J.P. Morgan 35th Annual Healthcare Conference GlobeNewswire +6.49%
Jan-01-17 02:08PM  3 Myths About Marijuana Stocks at Motley Fool
Dec-30-16 01:36PM  The 2016 Election Was A Tipping Point For Marijuana Stocks at Forbes
Dec-27-16 08:05AM  The 10 Largest Marijuana Companies at 24/7 Wall St.
Dec-14-16 10:52AM  The Worst Biopharma CEOs of 2016 Are ...
Dec-13-16 11:21AM  INVESTOR ALERT: Investigation of Insys Therapeutics Announced by Holzer & Holzer Business Wire
Dec-12-16 03:04PM  Marijuana Investing in 2017: 5 Numbers Everyone Should Know at Motley Fool
Dec-10-16 01:42PM  Is Cardinal Financial Corporation (CFNL) A Good Stock To Buy? at Insider Monkey
Dec-09-16 05:19PM  What Happened to Marijuana Stocks in 2016? at Motley Fool
04:32PM  Insys Stock Topples On Bribery, Fraud Arrests Of Former Executives
07:21AM  This Marijuana Company's in Hot Water With the DOJ at Motley Fool
12:14AM  Business Watch at The Wall Street Journal
Dec-08-16 07:39PM  [$$] Business Watch at The Wall Street Journal -11.87%
07:15PM  Ex-Insys executives arrested for bribing U.S. doctors to prescribe painkiller Reuters
07:11PM  [$$] Former Insys CEO Arrested in Opioid Prescription Kickback Case at The Wall Street Journal
05:55PM  After-hours buzz: INSY, LGF, TIME & more at CNBC
03:50PM  Insys Therapeutics, Inc. Issues Statement Regarding Department of Justice Press Release GlobeNewswire
03:21PM  Insys Therapeutics plummets 16% after several former executives, employees were arrested, charged by DOJ at MarketWatch
01:06PM  Six ex-Insys executives arrested in U.S. in fentanyl bribe case
04:04AM  Hedge Funds Are Betting On Insys Therapeutics Inc (INSY) at Insider Monkey
Dec-07-16 03:09PM  Canadian Marijuana Market More Mature, Outperforms U.S. Market
10:27AM  [video]4 Stocks You Can Buy to Profit From the Rising Use of Medical Marijuana
Dec-05-16 03:06PM  Top Marijuana Stocks to Buy in 2017 at Motley Fool
12:14PM  ETFs with exposure to INSYS Therapeutics, Inc. : December 5, 2016
Dec-03-16 03:37PM  Rating Marijuana Stocks: Less Risky, More Risky, Most Risky at Motley Fool
Dec-02-16 02:47PM  The Worst Marijuana Stocks in 2016 at Motley Fool
Nov-23-16 01:06PM  ETFs with exposure to INSYS Therapeutics, Inc. : November 23, 2016
08:30AM  Fentanyl billionaire comes under fire as death toll mounts from prescription opioids at MarketWatch
07:31AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : INSY-US : November 23, 2016
Nov-22-16 11:52PM  [$$] Fentanyl Billionaire Comes Under Fire as Death Toll Mounts From Prescription Opioids at The Wall Street Journal -7.47%
05:24PM  Medtronic, Patterson Among Day's Biggest Losers, Trump Continues to Pressure Healthcare Sector
11:14AM  [$$] Fentanyl Billionaire Comes Under Fire as Death Toll Mounts From Prescription Opioids at The Wall Street Journal
Nov-18-16 09:43AM  INSYS Therapeutics, Inc. :INSY-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016
07:00AM  Insys Therapeutics, Inc. to Present at Piper Jaffray 28th Annual Healthcare Conference GlobeNewswire
Nov-15-16 07:07AM  Even in a Trump Presidency, Marijuana Is a Good Investment
Nov-12-16 11:41AM  What's Next for Marijuana Stocks Now That Trump's Won? at Motley Fool
Nov-11-16 01:04PM  INSYS THERAPEUTICS, INC. Financials
07:06AM  INSYS Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : INSY-US : November 11, 2016
Nov-09-16 04:09PM  Nasdaq Cannabis Stocks Rally After Recreational and Medical Use Passes +15.40%
12:50PM  Marijuana Vote Could Boost These Stocks (SMG, INSY) at Investopedia
Nov-08-16 03:42PM  INSYS Therapeutics, Inc.: Gathering momentum, can it sustain its performance?
Nov-07-16 03:52PM  Nasdaq Cannabis Stocks Spike in Volume Ahead of Election for Recreational and Medical Use +12.16%
Nov-04-16 04:07PM  There's an alliance fighting to keep marijuana illegal +6.69%
02:01PM  Edited Transcript of INSY earnings conference call or presentation 3-Nov-16 2:00pm GMT
Nov-03-16 10:58AM  Insys Therapeutics tops 3Q profit forecasts
09:02AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
08:36AM  Insys Therapeutics Pops On Earnings Beat, But Revenues Plunge at Forbes
07:07AM  Q3 2016 INSYS Therapeutics Inc Earnings Release - Before Market Open
07:00AM  Insys Therapeutics Reports Third Quarter 2016 Results GlobeNewswire
Oct-29-16 02:01PM  5 Charts That Explain the Best Marijuana Stock at Motley Fool
Oct-27-16 05:00PM  Insys Therapeutics to Report Third Quarter 2016 Results GlobeNewswire
Oct-26-16 07:48AM  Big Pharma Is Fighting Legalized Marijuana Any Way It Can
Oct-19-16 01:30PM  Business owners replace idealists in legal-pot movement
Oct-15-16 05:11PM  How the Opioid Epidemic Is Changing 2 Drugmakers' Fortunes at Motley Fool
Oct-14-16 02:41PM  2 Marijuana Stocks That Are Going in Opposite Directions at Motley Fool -6.36%
09:49AM  New Colombia Resources Forming Joint Venture to Apply for an Orphan Drug Designation with the Food and Drug Administration (FDA) for a Medical Cannabis Pharmaceutical Product PR Newswire
Oct-13-16 09:29AM  Falling Earnings Estimates Signal Weakness Ahead for INSYS Therapeutics (INSY)
06:50AM  Insys Therapeutics Reports Preliminary Estimated Revenues from Subsys for the Third Quarter 2016 GlobeNewswire
Oct-06-16 03:29PM  Why This Marijuana Stock Crashed 18% in September at Motley Fool
Oct-04-16 10:00AM  ETFs with exposure to INSYS Therapeutics, Inc. : October 4, 2016
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MEYER STEVEN JDirectorNov 04Buy10.7510,000107,48944,083Nov 07 10:14 AM
MEYER STEVEN JDirectorSep 01Option Exercise13.575006,78534,083Sep 01 04:23 PM
STANLEY THEODORE HDirectorAug 16Option Exercise5.9615,00089,40017,000Aug 16 08:23 PM
STANLEY THEODORE HDirectorAug 16Sale18.0215,000270,3002,000Aug 16 08:23 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerAug 12Buy18.575,700105,85342,430,310Aug 12 03:40 PM
FOURTEAU PATRICKDirectorAug 11Sale18.4615,000276,90049,682Aug 12 04:51 PM
BRENNAN DANIELExec VP & Chf Operations Off.Aug 09Sale19.165,781110,7521Aug 09 07:12 PM
MEYER STEVEN JDirectorAug 04Option Exercise14.081,19416,80633,583Aug 04 06:49 PM
MEYER STEVEN JDirectorJul 06Option Exercise14.4469510,03632,389Jul 06 04:12 PM
MEYER STEVEN JDirectorJun 07Option Exercise14.081,19416,80631,694Jun 07 09:33 PM
BAKER DARRYL SChief Financial OfficerMay 23Option Exercise13.5710,000135,70021,030May 23 04:40 PM
MEYER STEVEN JDirectorMay 18Option Exercise13.575006,78530,500May 18 04:39 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 12Buy12.4110,000124,11942,424,610May 12 07:06 PM
JOHN N KAPOOR TRUST DATED SEPT10% OwnerMay 11Buy12.9440,000517,70842,414,610May 12 07:06 PM
MEYER STEVEN JDirectorApr 14Option Exercise4.8712,00058,47030,000Apr 14 06:54 PM
FOURTEAU PATRICKDirectorMar 04Sale18.2215,000273,30064,682Mar 04 04:52 PM